Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies Inc (MIR) delivers critical radiation safety solutions for nuclear energy, healthcare, and global security markets. This news hub provides investors and industry professionals with essential updates on the company developments shaping radiation detection technologies.
Access timely reports covering earnings announcements, product innovations, strategic partnerships, and regulatory milestones. Our curated collection features press releases and analysis on Mirion's Nuclear & Safety segment advancements and Medical division breakthroughs in cancer treatment safety.
Key updates include radiation monitoring system launches, international expansion efforts, and R&D initiatives addressing emerging nuclear safety challenges. Bookmark this page for structured access to operational updates from Mirion's global facilities and executive leadership commentary.
For stakeholders tracking radiation protection technologies, this resource offers comprehensive monitoring of Mirion's progress in dosimetry systems, environmental monitoring solutions, and medical radiation processing advancements. Return regularly for verified updates maintaining compliance with financial disclosure standards.
Mirion Technologies, Inc. (NYSE: MIR) reported a 1.8% decrease in revenues for Q1 2022, totaling $163.2 million. The net loss improved to $19.0 million from $40.7 million year-over-year. Adjusted EBITDA fell 12.5% to $34.9 million. The company updated its 2022 guidance, forecasting organic adjusted revenue growth of 4%-6% and adjusted EBITDA of $170-$180 million. Despite challenges from supply chain issues and the Ukraine conflict, Mirion remains optimistic about its business strategy and order inflows.
Mirion Technologies, Inc. (NYSE: MIR) announced the release of the SunSCAN™ 3D cylindrical water scanning system by its subsidiary Sun Nuclear Corporation.
The system improves radiation therapy workflows, offering hyper-accurate dosimetry with a precision of 0.1 mm for stereotactic treatments. It features faster setup times and new SunDOSE™ software for enhanced quality assurance.
Demonstrations will take place at the ESTRO 2022 conference from May 6-10 in Copenhagen, with an online release event on May 17.
Mirion Technologies (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Goldman Sachs Industrials and Materials Conference on May 10, 2022, at 11:20 AM ET in New York, NY. The presentation will be available for live streaming on their website, with an archived version accessible for two weeks after the event. Mirion Technologies specializes in detection and monitoring solutions across various sectors, including nuclear and defense, and operates in 13 countries.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Wells Fargo’s 2022 Industrials Conference on Thursday, May 5, 2022, at 12:00 PM ET in New York, NY.
The presentation will be webcast live and accessible at Mirion's website, where it will be archived for two weeks following the event. Mirion provides detection, measurement, analysis, and monitoring solutions across various sectors, employing around 2,600 people globally.
Mirion Technologies (NYSE: MIR) will release its financial results for the first quarter of 2022 on May 4, 2022, followed by a conference call at 11:00 am ET. Participants can join by calling 1-844-826-3033 or 1-412-317-5185. A live webcast will also be available at Mirion's Investor page. A telephonic replay will be accessible until May 18, 2022. Mirion is a leader in detection, measurement, and analysis solutions for various markets, including nuclear and medical, employing around 2,600 people across 13 countries.
Mirion Technologies (NYSE: MIR) has announced an upgraded Cloud-hosted, SaaS option for its SunCHECK™ Quality Management Platform. This platform enhances workflows for Radiation Therapy Quality Assurance, improving patient safety and reducing operational burdens. The SaaS model offers better scalability and reliability, utilizing Amazon Web Services for infrastructure. Over 1,600 users currently utilize SunCHECK software, showcasing its significance in cancer care. The SaaS solution is designed to meet diverse clinic needs and will be demonstrated at ESTRO 2022 in Copenhagen.
Mirion Technologies reported a 18% increase in revenue for Q4 2021, totaling $177.8 million, compared to $150.8 million in Q4 2020. The company posted a GAAP net loss of $23.0 million for the same period. Adjusted EBITDA rose to $44.5 million, up from $31.2 million in the previous quarter. For the fiscal year 2022, Mirion forecasts adjusted revenue growth between 5.5% and 7.5% and adjusted EBITDA of $175 million to $185 million. The company is facing supply chain challenges but remains confident in its growth prospects.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Citi Global Industrial Tech and Mobility Conference in Miami, FL, on February 24, 2022, at 1:50 PM ET. The presentation will be webcast live, with an archived version available afterward. Mirion is a premier provider of detection and monitoring solutions for nuclear, defense, and medical sectors and operates in 13 countries, employing around 2,600 people. For additional details, visit Mirion.com.
Mirion Technologies, Inc. (NYSE: MIR) will release its financial results for the fourth quarter and fiscal year ended
Kaman Composites – Vermont, a subsidiary of Kaman Corporation (NYSE:KAMN), has partnered with Mirion Technologies (NYSE:MIR) to expand its medical imaging program. This collaboration involves Kaman supplying surgical C-Arm tabletops, with the first deliveries scheduled for Q2 2022. Kaman Composites possesses 40 years of expertise in designing composite components and is recognized for its rigorous manufacturing standards. This partnership signifies Kaman's growing presence in the medical technology sector while maintaining its aerospace industry role.
FAQ
What is the current stock price of Mirion Technologies (MIR)?
What is the market cap of Mirion Technologies (MIR)?
